Skip to content

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01692938
Enrollment
32
Registered
2012-09-26
Start date
2012-10-31
Completion date
2012-11-30
Last updated
2017-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration, Central Serous Retinopathy, Diabetic Retinopathy, Epiretinal Membrane, Geographic Atrophy, Macular Edema, Macular Hole, Pattern Dystrophy of Macula, Retinal Vein Occlusion

Brief summary

To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, and variability within a subject for a single operator-device configuration.

Interventions

None listed

Sponsors

Johns Hopkins University
CollaboratorOTHER
University of Southern California
CollaboratorOTHER
Optos, PLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject must be 21 years of age or older. * Subjects recruited to Cohort 1 will have no known retinal disease except for refractive errors (-7.5 D to +7.5 diopters).Subjects who are recruited to Cohort 2 will have one or more of the following retinal pathologies: early and intermediate Age-Related Macular Degeneration, Geographic Atrophy, Diabetic Retinopathy (mild, moderate, severe), Macular Edema secondary to Diabetes, Retinal Vein Occlusion, Central Serous Retinopathy, Pattern Dystrophy, Epiretinal Membrane or Macular Hole. * Subjects who have signed an informed consent form. * Subjects who can comply with the protocol.

Exclusion criteria

* Subjects younger than 21 years of age. * Subjects who cannot comply with the protocol. * Subjects who cannot complete the Simple Test procedures * Subjects who are not available to be testing 3 times during the day (Morning, Mid - Day, and Afternoon). * Subjects with visual acuity worse than 20/100 (Best Corrected). * Subjects with dense media opacities. * Ocular surgery anticipated on the day of the study visit.

Design outcomes

Primary

MeasureTime frameDescription
Standard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations1 MonthA precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. For each subject, one eye was evaluated using 3 tests with repositioning at the start of each test. Test results were given in decibels which is the unit used in microperimetry testing. Overall mean and standard deviation in decibels were calculated for the two groups: normal and with pathology.
Repeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.1 MonthA precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. Test results were given in decibels as that is the standard measurement in microperimetry testing. For each subject, one eye was evaluated using 3 microperimetry tests with repositioning at the start of each test. Overall Repeatability SD and Repeatability SD Limit were calculated for the two groups: normal and with pathology.

Countries

United States

Participant flow

Recruitment details

Recruitment Dates - 10/5/2012 to 11/5/2012. 3 Ophthalmic Clinics.

Participants by arm

ArmCount
No Retinal Disease12
Retinal Disease12
Total24

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Deviation11
Overall StudyStudy completed prior to site completion33

Baseline characteristics

CharacteristicNo Retinal DiseaseRetinal DiseaseTotal
Age, Customized
21-35 years
4 participants3 participants7 participants
Age, Customized
36-50 years
4 participants3 participants7 participants
Age, Customized
51-64 years
3 participants3 participants6 participants
Age, Customized
65 years or great
1 participants3 participants4 participants
Sex: Female, Male
Female
8 Participants6 Participants14 Participants
Sex: Female, Male
Male
4 Participants6 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 16
serious
Total, serious adverse events
0 / 160 / 16

Outcome results

Primary

Repeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.

A precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. Test results were given in decibels as that is the standard measurement in microperimetry testing. For each subject, one eye was evaluated using 3 microperimetry tests with repositioning at the start of each test. Overall Repeatability SD and Repeatability SD Limit were calculated for the two groups: normal and with pathology.

Time frame: 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
No Retinal DiseaseRepeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.Repeatability SD16.16 decibelsStandard Deviation 0.531
No Retinal DiseaseRepeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.Repeatability SD Limit16.16 decibelsStandard Deviation 1.49
Retinal DiseaseRepeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.Repeatability SD12.23 decibelsStandard Deviation 0.682
Retinal DiseaseRepeatability of Microperimetry Tests in Normal and With Pathology Participants Based on 3 Microperimetry Tests Taken for Each Participant for a Given Operator-device Combination.Repeatability SD Limit12.23 decibelsStandard Deviation 1.91
Primary

Standard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations

A precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. For each subject, one eye was evaluated using 3 tests with repositioning at the start of each test. Test results were given in decibels which is the unit used in microperimetry testing. Overall mean and standard deviation in decibels were calculated for the two groups: normal and with pathology.

Time frame: 1 Month

ArmMeasureValue (MEAN)Dispersion
No Retinal DiseaseStandard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations16.16 decibelsStandard Deviation 1.735
Retinal DiseaseStandard Deviation and Mean Test Results of Normal and With Pathology Participants Taken by 3 Different Operator-device Configurations12.23 decibelsStandard Deviation 3.508

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026